Literature DB >> 20232289

Exploring the influence of proximity to death on disease-specific hospital expenditures: a carpaccio of red herrings.

Albert Wong1, Pieter H M van Baal, Hendriek C Boshuizen, Johan J Polder.   

Abstract

It has been demonstrated repeatedly that time to death is a much better predictor of health care expenditures than age. This is known as the 'red herring' hypothesis. In this article, we investigate whether this is also the case regarding disease-specific hospital expenditures. Longitudinal data samples from the Dutch hospital register (n=11 253 455) were used to estimate 94 disease-specific two-part models. Based on these models, Monte Carlo simulations were used to assess the predictive value of proximity to death and age on disease-specific expenditures. Results revealed that there was a clear effect of proximity of death on health care expenditures. This effect was present for most diseases and was strongest for most cancers. However, even for some less fatal diseases, proximity to death was found to be an important predictor of expenditures. Controlling for proximity to death, age was found to be a significant predictor of expenditures for most diseases. However, its impact is modest when compared to proximity to death. Considering the large variation in the degree to which proximity to death and age matter for each specific disease, we may speak not only of age as a 'red herring' but also of a 'carpaccio of red herrings'.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 20232289     DOI: 10.1002/hec.1597

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  22 in total

1.  Standardizing the inclusion of indirect medical costs in economic evaluations.

Authors:  Pieter H M van Baal; Albert Wong; Laurentius C J Slobbe; Johan J Polder; Werner B F Brouwer; G Ardine de Wit
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

2.  Testing the red herring hypothesis on an aggregated level: ageing, time-to-death and care costs for older people in Sweden.

Authors:  Martin Karlsson; Florian Klohn
Journal:  Eur J Health Econ       Date:  2013-07-19

Review 3.  The effect of population aging on health expenditure growth: a critical review.

Authors:  Claudine de Meijer; Bram Wouterse; Johan Polder; Marc Koopmanschap
Journal:  Eur J Ageing       Date:  2013-05-15

4.  Cost-effectiveness of preventive interventions to reduce alcohol consumption in Denmark.

Authors:  Astrid Ledgaard Holm; Lennert Veerman; Linda Cobiac; Ola Ekholm; Finn Diderichsen
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

5.  Disease prevention: saving lives or reducing health care costs?

Authors:  Inge Grootjans-van Kampen; Peter M Engelfriet; Pieter H M van Baal
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

6.  Risk adjustment in aging societies.

Authors:  Viktor von Wyl; Konstantin Beck
Journal:  Health Econ Rev       Date:  2014-08-09

7.  To What Extent Is Long-term Care Representative of Elderly Care? A Case Study of Elderly Care Financing in Lombardy, Italy.

Authors:  Elenka Brenna; Lara Gitto
Journal:  Int J Health Policy Manag       Date:  2017-08-01

8.  Trends in and drivers of healthcare expenditure in the English NHS: a retrospective analysis.

Authors:  Idaira Rodriguez Santana; María José Aragón; Nigel Rice; Anne Rosemary Mason
Journal:  Health Econ Rev       Date:  2020-06-30

9.  Place of death and health care utilization for people in the last 6 months of life in Switzerland: a retrospective analysis using administrative data.

Authors:  Oliver Reich; Andri Signorell; André Busato
Journal:  BMC Health Serv Res       Date:  2013-03-25       Impact factor: 2.655

10.  Changes in health care expenditure after the loss of a spouse: data on 6,487 older widows and widowers in the Netherlands.

Authors:  Herbert J A Rolden; David van Bodegom; Rudi G J Westendorp
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.